Azor and Miralax drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Azor (amlodipine besylate; olmesartan medoxomil) and Miralax (polyethylene glycol 3350). Common drug interactions include asthenia among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Azor and Miralax. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Azor?

Azor has active ingredients of amlodipine besylate; olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 3,922 Azor users. Check the latest studies of Azor.

What is Miralax?

Miralax has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 81,754 Miralax users. Check the latest studies of Miralax.

On Jul, 13, 2026

34 people who take Azor and Miralax together, and have interactions are studied.

What are the common drug interactions of Azor and Miralax, by gender? *:

female:

Asthenia (weakness)
Contusion (a type of hematoma of tissue in which capillaries)
Arthralgia (joint pain)
Drug ineffective
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Fall
Gait disturbance
Agitation (state of anxiety or nervous excitement)
Back pain

male:

Diarrhoea
Brain neoplasm (tumour of brain)
Epistaxis (bleed from the nose)
Intraductal papillary mucinous neoplasm (tumour (neoplasm) that grows within the pancreatic ducts)
Jugular vein thrombosis (clot in jugular vein)
Pancreatitis acute (sudden inflammation of pancreas)
Pulmonary embolism (blockage of the main artery of the lung)
Scotoma (an area of diminished vision within the visual field)
Death
Second primary malignancy (after getting cure a cancer, a new cancer development)

What are the common drug interactions of Azor and Miralax, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Abdominal pain lower
Abnormal behaviour
Aggression
Agitation (state of anxiety or nervous excitement)
Decreased appetite
Duodenitis (inflammation of the duodenum)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Haematochezia (passage of stools containing blood)
Haemoglobin decreased
Haemorrhoidal haemorrhage (bleeding from the haemorrhoids)

10-19:

n/a

20-29:

n/a

30-39:

Chronic kidney disease

40-49:

Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Epistaxis (bleed from the nose)
Jugular vein thrombosis (clot in jugular vein)
Pulmonary embolism (blockage of the main artery of the lung)

50-59:

Intraductal papillary mucinous neoplasm (tumour (neoplasm) that grows within the pancreatic ducts)
Pancreatitis acute (sudden inflammation of pancreas)

60+:

Brain neoplasm (tumour of brain)
Death
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Asthenia (weakness)
Contusion (a type of hematoma of tissue in which capillaries)
Cystitis (inflammation of the wall of the bladder)
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Duodenitis (inflammation of the duodenum)
Erythema (redness of the skin)
Fall

What are the existing conditions these people have? *

Pain: 5 people, 14.71%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 14.71%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 14.71%
Multiple Myeloma (cancer of the plasma cells): 4 people, 11.76%
Depression: 4 people, 11.76%
Hypersensitivity: 4 people, 11.76%
Malignant Melanoma (skin cancer rises from melancytes): 3 people, 8.82%
Insomnia (sleeplessness): 3 people, 8.82%
Thyroid Diseases: 2 people, 5.88%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Azor and Miralax?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously